Related Experiment Video
Updated: Jul 16, 2026

06:23
Assessment of Plasma Coagulation on Liver Tissue in a Large Animal Model In Vivo
Published on: August 4, 2018
Argon plasma coagulation for flexible endoscopic Zenker's diverticulotomy
T Rabenstein1, A May, J Michel
1Department of Medicine II, Dr.-Horst-Schmidt-Kliniken Wiesbaden, Wiesbaden, Germany. thomas.rabenstein@hsk-wiesbaden.de
Endoscopy
|March 1, 2007
Summary
Argon plasma coagulation (APC) is a safe and effective endoscopic treatment for Zenker's diverticulum, achieving high short-term success. Mid-term follow-up shows a 15% recurrence rate, necessitating retreatment in some patients.
Area of Science:
- Gastroenterology
- Endoscopy
- Surgical Innovation
Background:
- Zenker's diverticulum treatment is increasingly utilizing flexible endoscopy.
- Data on the safety and efficacy of endoscopic approaches for Zenker's diverticulum remains limited.
- This study evaluates mid-term outcomes of argon plasma coagulation (APC) for this condition.
Purpose of the Study:
- To report the mid-term results of argon plasma coagulation (APC) in flexible endoscopic treatment of Zenker's diverticulum.
- To assess the safety and efficacy of APC in a cohort of patients.
- To determine recurrence rates at mid-term follow-up.
Main Methods:
- A retrospective study involving 41 patients treated with APC flexible endoscopic Zenker's diverticulotomy between 2002 and 2006.
- Technical success and immediate clinical success (3-month follow-up) were evaluated.
- Mid-term follow-up data were collected for 34 patients with a mean follow-up of 16 months.
Main Results:
- All 41 patients achieved technical success, with an average of 3 treatment sessions.
- Immediate clinical success was observed in 95% of patients.
- A 15% recurrence rate was noted at mid-term follow-up, with successful retreatment using APC.
Conclusions:
- Argon plasma coagulation (APC) is a safe and effective short-term endoscopic treatment for Zenker's diverticulum.
- Approximately 15% of patients may experience recurrence within mid-term follow-up.
- Prospective randomized studies are needed to compare APC with other techniques like needle-knife therapy.